4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-034087
Options or other derivatives
- Chief Medical Officer acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schelman William Chief Medical Officer | 2026-05-08 | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | D | ||
Loading xslF345X06/wk-form4_1778616247.xml…